Boehringer Ingelheim and ViraTherapeutics collaborate to boost immune-oncology pipeline
29 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Under the terms of the collaboration, Boehringer Ingelheim receives the right to acquire ViraTherapeutics after conclusion of Phase I clinical development...